Vaccinations May Become Needle-Free with Novel Oral Delivery System

Lauren Santye, Assistant Editor
Published Online: Thursday, March 9th, 2017
Needleless, pill-sized vaccines may one day become a reality, according to a proof-of-concept study published in Science Translational Medicine.
 
The study demonstrated that the technology MucoJet can deliver vaccine-sized molecules to immune cells in the mouths of animals, bringing society one step closer to improved oral vaccine delivery.
 
The MucoJet is placed against the inside of an individual’s cheek and releases a jet stream that directly targets the buccal region. The mouth’s buccal region has an abundance of immune cells and is an area where many infections enter the body.
 
Penetrating the thick mucosal layer in this part of the oral cavity has proven to be a challenge with existing technology, such as oral spray used for influenza vaccination.
 
The results of the study showed that the MucoJet could deliver a high-pressure stream of liquid and immune system-triggering molecules that penetrate the mucosal layer to stimulate an immune response in the buccal region.
 
Although the jet of the self-administered device is pressurized, the authors said it is not uncomfortable and would remove the sting of needles. “This jet is similar in pressure to a water pick that dentists use,” said Kiana Aran, who developed the technology.
 
The portable technology stores vaccines in powder form and could one day delivery vaccines to remote locations, but years of further research is needed before the device would become commercially available.
 
The following are the specs of the MucoJet:
1.     15 X 7 mm cylindrical 2-compartment plastic device
2.     Solid components are 3D-printed from an inexpensive biocompatible and water-resistant plastic resin
3.     Exterior department holds 250 ml of water
4.     Interior compartment is composed of 2 reservoirs separated by a porous plastic membrane and movable piston.
a.     Vaccine reservoir contains a 100-ml chamber of vaccine solution with a piston at one end and a sealed 200-m diameter delivery nozzle at the other end
b.     Propellant reservoir contains the dry chemical propellant citric acid and sodium bicarbonate. It’s separated from the vaccine reservoir at one end by the built-in porous membrane and    movable piston, and is sealed at the other end from the exterior compartment with a dissolvable membrane
 
To administer the MucoJet, a patient clicks together the interior and exterior compartments. The membrane then dissolves, the water contacts the chemical propellant, and the ensuing chemical generates carbon dioxide gas. The gas increases the pressure in the propellant chamber, causing the piston to move, ensuring uniform movement of the ejected drug and blocks the exit of fizz from the carbon dioxide through the nozzle. One the pressure in the propellant chamber is high enough, the force on the piston breaks the nozzle seal of the vaccine reservoir. The vaccine solution is then ejected from the device’s nozzle and penetrates the mucosal layer of the buccal tissue to deliver the vaccine to antigen-presenting cells.
 


Current Issue

The Educated Patient

Bethany Rettberg, NPC
Practitioners should get a detailed medical history and conduct a thorough physical to treat sinus infections.
Jennifer L. Hofmann, MS, PA-C
Providing them with advice can improve control of the disease and reduce hospitalizations, morbidity, and unscheduled health care visits.
Emily C. Hayes, PharmD Candidate
Colds, coughs, and a relentless influx of sick patients in retail health clinics keep the health care providers who work there very busy.
Kristen Marjama, DNP, APRN-BC
Although the rate of foot and leg amputation has greatly declined over the past 2 decades, increasing awareness for macrovascular and microvascular complications of diabetes is essential because diabetes is the leading cause of lower-limb amputations in the United States.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
ONCLive
OTCGuide
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Advertise
Careers
Contact Us
Feedback
Privacy
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2019
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.